Tennessee · 114th Regular Session (2025-2026) · Bill

SB 2499: TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

In committee Last action March 10, 2026: Assigned to General Subcommittee of Senate Commerce and Labor Committee

Plain-language summary

SB 2499 is a bill introduced in the Tennessee Senate on February 2, 2026. According to its official title, it concerns: TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71. Primary sponsor: Sara Kyle (Democratic). Most recent recorded action (March 10, 2026): Assigned to General Subcommittee of Senate Commerce and Labor Committee.

Sponsors

Primary sponsor: Sara Kyle (Democratic).